Clozapine-resistant schizophrenia: A positive approach

British Journal of Psychiatry

Volumn 181, Issue SEPT., 2002, Pages 184-187

  Williams, Lisa ^a   Newton, Graham ^a   Roberts, Kathryn ^a   Finlayson, Sara ^a   Brabbins, Clare ^a  

^a Hesketh Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CLOZAPINE; FLUOXETINE; FLUVOXAMINE; LAMOTRIGINE; LOXAPINE; NEUROLEPTIC AGENT; PAROXETINE; PIMOZIDE; SULPIRIDE; VALPROIC ACID;

ANAMNESIS; CLINICAL FEATURE; CLINICAL TRIAL; COMPLIANCE (PHYSICAL); EDITORIAL; ELECTROCONVULSIVE THERAPY; EMOTION; FAMILY THERAPY; HUMAN; HUMAN RELATION; MOOD; NEGATIVE SYNDROME; SCHIZOPHRENIA; SOCIAL PSYCHOLOGY; THOUGHT DISORDER; TREATMENT INDICATION;

ANTIPSYCHOTIC AGENTS; CLOZAPINE; DRUG RESISTANCE; FAMILY; HUMANS; PSYCHOTHERAPY; SCHIZOPHRENIA;

EID: 0036729839     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.181.3.184     Document Type: Editorial

References (41)

1. Concurrent administration of clozapine and ECT: A successful therapeutic strategy for a patient with treatment-resistant schizophrenia
2. Predicting relapse in schizophrenia: The development and implementation of an early signs monitoring system using patients and families as observers
3. Neuroleptic-resistance schizophrenia treated with clozapine and ECT
4. Fluoxetine augmentation of clozapine treatment in patients with schizophrenia
5. Serum concentrations of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors
6. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: A review and meta-analysis of randomised trials
7. Cognitive behavioural psychotherapy for schizophrenia: A review of recent empirical studies
8. The effectiveness of olanzapine in treatment-refractory schizophrenia when patients are non-responsive to or unable to tolerate clozapine
9. Clozapine plus lamotrigine in treatment resistant schizophrenia
10. Expressed emotion on long stay wards
11. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine
12. The thorn nursing initiative
13. London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. II: Predictors of outcome
14. Olanzapine augmentation of clozapine
15. Nurses, patients and relatives: A study of family patterns on psychiatric wards
16. Psychological treatments for negative symptoms
17. Elective combined electroconvulsive and clozapine therapy
18. Combined electroconvulsive therapy and clozapine in treatment resistant schizophrenia
19. Concurrent use of clozapine and valproate in affective and psychotic disorders
20. Randomised controlled trial of compliance therapy. 18-Month follow-up
21. Cognitive behaviour therapy of schizophrenia
22. Fluvoxamine increases the clozapine serum levels significantly
23. London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. I: Effects of the treatment phase
24. London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. III: Follow-up of economic evaluation at 18 months
25. Effects of training in psychosocial interventions for community psychiatric nurses
26. Fluvoxamine-clozapine dose-dependent interaction
27. Risperidone and clozapine combination for the treatment of refractory schizophrenia
28. Adjunctive loxapine in a clozapine-resistant cohort of schizophrenic patients
29. Cognitive-behavioural therapy and clozapine for clients with treatment-refractory schizophrenia
30. Clozapine and risperidone combination/augmentation treatment of refractory schizophrenia: A preliminary observation
31. A randomised controlled trial of cognitive-behavioural therapy for persistent symptoms in schizophrenia resistant to medication
32. Sulpiride augmentation in people with schizophrenia partially responsive to clozapine. A double-blind, placebo-controlled study
33. Newer atypical antipsychotic medication versus clozapine for schizophrenia
34. The influence of family and social factors on the course of psychiatric illness. A comparison of schizophrenic and depressed neurotic patients
35. Risperidone versus clozapine in treatment-resistant schizophrenia: A randomised pilot study
36. Olanzapine for treatment-refractory psychosis in patients responsive to, but intolerant of, clozapine